Clinical Research to Explore Manifestations of Heart Failure Using Infrared Thermal Imaging Technology
1 other identifier
observational
200
1 country
4
Brief Summary
The purpose of this study is to explore manifestations of Heart Failure Using Infrared Thermal Imaging Technology.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2015
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2015
CompletedFirst Submitted
Initial submission to the registry
January 26, 2016
CompletedFirst Posted
Study publicly available on registry
February 3, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2017
CompletedFebruary 3, 2016
February 1, 2016
1.2 years
January 26, 2016
February 2, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Surface temperature (℃）of face and hand measured by Infrared (IR) camera
up to 12 months
Secondary Outcomes (4)
LVEF（left ventricular ejection fraction）
up to 12 months
proBNP(pro Brain Natriuretic Peptide)
up to 12 months
catecholamine levels
up to 12 months
Entropy of thermal image
up to 12 months
Study Arms (3)
chronic heart failure
18-85years old,having symptoms of heart failure,New York Heart Association（NYHA） class II or above American College of Cardiology/American Heart Association（ACC/AHA） class B, C, including hypertensive heart disease, rheumatic heart disease, ischemic cardiomyopathy and idiopathic cardiomyopathy
normalCardiac function
18-85years old,no symptoms of heart failure,NYHA class I or above ACC/AHA class A, including controled hypertension,stability coronary heart disease and rheumatic heart disease
healthy volunteers
18-85years old,Without basic cardiovascular diseases
Eligibility Criteria
Heart failure patients included in this study had been definitively diagnosed as having with Echocardiography. The healthy volunteer group matched the HF group in number, age, and gender.
You may qualify if:
- Willing to participate in the trial and sign the informed consent form
- Aged: 18-85 years
- Was diagnosed as heart failure
- There is no trauma, infection, biopsy or puncture, hemorrhage and tumor in the corresponding detection site (face)
- There is no skin disease, heart, liver, kidney, gastrointestinal tract, hematopoietic system and mental, neurological has no serious diseases
You may not qualify if:
- Fever causes by any reasons, temperature higher than 37.4℃
- Infection
- Renal failure
- Cerebrovascular diseases
- Moderate anemia or more
- Not willing to participate in clinical trials
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jing Huanglead
Study Sites (4)
The 2nd Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, 400010, China
3Rd People'S Hospital of Chengdu
Chengdu, Sichuan, China
The First Affiliated Hospital of Sichuan Medical University:
Luzhou, Sichuan, China
The First Affiliated Hospital of Chongqing Medical University:
Chongqing, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
hang jing
Chongqing Medical University
Central Study Contacts
Study Design
- Study Type
- observational
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- professor，vice director
Study Record Dates
First Submitted
January 26, 2016
First Posted
February 3, 2016
Study Start
November 1, 2015
Primary Completion
January 1, 2017
Study Completion
June 1, 2017
Last Updated
February 3, 2016
Record last verified: 2016-02
Data Sharing
- IPD Sharing
- Will share